CancerWorld Issue #113 (March) is Live!
Princess Dina Mired: Nurses at the Heart of Childhood Cancer Care
Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026
Jérôme Salomon: History of Preventive Medicine
At Least 40 Hours of Nutrition Education in Medical Schools - Kennedy and McMahon
Newly Diagnosed AML: 2026 Treatment Algorithms - Resonance
Miriam Mutebi: Inspiring the Next Generation of Women Surgeons in Africa
Sam Stevens: How Common Sense Oncology Can Help to Make a Tangible Difference in the Pacific Region
The ESMO webinar "Therapeutic Landscapes: Toxicity of Cellular Therapies 2026" is a specialized virtual educational session scheduled for January 21, 2026, at 18:30 CET. Led by chairs and speakers Claire […]
The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive, single-day educational symposium scheduled for January 24, 2026, in Jeddah, Saudi Arabia. Organized by the European Society for Medical Oncology (ESMO), this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle […]
The ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time). Register.
The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO). Scheduled for January 31, 2026, in Sofia, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented […]
The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive bladder cancer (MIBC). Scheduled for February 4, 2026, this virtual symposium addresses the clinical challenges of MIBC, which is characterized by high morbidity and mortality. […]
The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management, including screening, prevention, diagnosis, and the standard of care for early, locally advanced, recurrent, and metastatic disease. The event is scheduled for February 5–6, 2026, in Cape Town, South […]
The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town, South Africa, from 6 to 8 February 2026, […]
The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday, February 9, 2026, from 14:00 to 15:00 CET. This interactive Clinical Case Discussion, titled "Pregnancy-associated cancer: Clinical challenges and ethical insights," is designed to provide young oncologists with a platform to engage with experts on complex […]
The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. The live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging […]
The 1st Best of ESMO Levant is scheduled to take place on February 12–13, 2026, in Sulaymaniyah, Iraq. Organized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with ESMO, this landmark regional conference is designed to bring the most critical clinical updates and practice-changing research from recent ESMO congresses to the Levant region. […]
ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18, 2026, focused on the safety profiles and clinical management of next-generation biologics. Chaired by Elena Garralda, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion […]
The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). Scheduled for March 4, 2026, this virtual session focuses on the technical challenges of managing advanced disease where […]
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]
The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, […]
